Timolol Maleate is a drug owned by Sandoz Inc. It is protected by 2 US drug patents filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Sep 26, 2019. Details of Timolol Maleate's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
|
US6174524 (Pediatric) | Gelling ophthalmic compositions containing xanthan gum |
Sep, 2019
(5 years ago) |
Expired
|
| US6174524 | Gelling ophthalmic compositions containing xanthan gum |
Mar, 2019
(5 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Timolol Maleate is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Timolol Maleate's family patents as well as insights into ongoing legal events on those patents.
Timolol Maleate's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Timolol Maleate's generic launch date based on the expiry of its last outstanding patent is estimated to be Sep 26, 2019 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Timolol Maleate Generic API suppliers:
Timolol Maleate is the generic name for the brand Timolol Maleate. 31 different companies have already filed for the generic of Timolol Maleate, with Epic Pharma Llc having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Timolol Maleate's generic
Alternative Brands for Timolol Maleate
There are several other brand drugs using the same active ingredient (Timolol Maleate) as Timolol Maleate. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
Apart from brand drugs containing the same ingredient, some generics have also been filed for Timolol Maleate, Timolol Maleate's active ingredient. Check the complete list of approved generic manufacturers for Timolol Maleate
About Timolol Maleate
Timolol Maleate is a drug owned by Sandoz Inc. Timolol Maleate uses Timolol Maleate as an active ingredient. Timolol Maleate was launched by Sandoz in 1998.
Approval Date:
Timolol Maleate was approved by FDA for market use on 21 October, 1998.
Active Ingredient:
Timolol Maleate uses Timolol Maleate as the active ingredient. Check out other Drugs and Companies using Timolol Maleate ingredient
Dosage:
Timolol Maleate is available in solution, gel forming/drops form for ophthalmic use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| EQ 0.5% BASE | SOLUTION, GEL FORMING/DROPS | Prescription | OPHTHALMIC |
| EQ 0.25% BASE | SOLUTION, GEL FORMING/DROPS | Prescription | OPHTHALMIC |